Transgender teens on the Minnesota Medicaid program are now eligible for transition-related medications that had been routinely denied for years.
Doctors who care for transgender youth say the change will make a big difference because it will give them more options as they progress toward adulthood. "Treatment delay has put adolescents at risk," said Dr. Kelsey Leonardsmith of Family Tree Clinic in St. Paul. "I've been pleased with our ability to get these vital lifesaving medications."
The change in policy by the Minnesota Department of Human Services (DHS) also extends to the MinnesotaCare insurance program. While doctors and transgender health care advocates applaud the decision, they say that some private insurance plans are still denying the needed medications or making it difficult to get them. "I have seen outright denials where no amount of advocacy makes a difference," said Leonardsmith.
About 3% of Minnesota high schoolers identify as gender diverse, meaning that their gender identity differs from their sex assigned at birth. It also could mean that they are in flux or consider themselves neither exclusively male or female.
The new Medicaid policy, which took effect in August, allows doctors to prescribe hormones, such as testosterone, for those who have decided to transition.
It also provides coverage for puberty blockers, which prevent the physical progression of puberty.
"These medications basically are a pause button so that patients can work with their therapists and doctors in order to come to better terms with their gender and then make a more adult decision about how to proceed with their puberty progression when the time comes," said Dr. Christopher Dunne, an endocrinologist at the gender health program at Children's Minnesota.
"Going through puberty of the wrong sex can be very distressing for adolescents who are transgender," said Dunne. "Puberty is hard enough already, and then if you add being transgender on top of that it is even more distressing."